Nemaura Medical Inc. (NASDAQ: NMRD) Starts Presentation at The LD 500
Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT(R) and proBEAT(TM). SugarBEAT(R), a CE mark-approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (CGM) providing actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and pre-diabetes better manage, reverse and prevent the onset of diabetes. Nemaura has also submitted a PMA application for sugarBEAT(R) to the U.S. FDA. ProBEAT(TM) comprises a non-invasive glucose monitor and a digital health care subscription service and is due to be launched…







